Expressão genica global e estudo do gene JUNB em policitemia vera / Global gene expression and study of the JUNB gene in polycythemia

AUTOR(ES)

Barbara da Costa Reis Monte-Mor

DATA DE PUBLICAÇÃO

2007

RESUMO

Polycythemia vera (PV) is a chronic myeloproliferative disorder that arises through clonal proliferation of multipotent hematopoietic progenitors. PV patients present bone marrow trilineage expansion, leading to increased production of mature red cells, granulocytes and platelets. Important PV features are elevated red cell mass, despite normal or subnormal erythropoietin (EPO) levels, and endogenous erythroid colony (EEC) formation. The JAK2 V617F mutation, present in the majority of polycythemia vera (PV) patients, causes a JAK2 constitutive activation and seems to be responsible for the PV phenotype. However, the transcriptional changes triggered by the mutation have not yet been totally characterized. Serial analysis of gene expression (SAGE) was used to perform a large scale gene expression study in bone marrow cells of a newly-diagnosed PV patient harboring the JAK2 V617F mutation and in normal bone marrow cells from healthy donors. Genes overexpressed in PV are involved in important biological processes, such as signal transduction, cellular differentiation, cellular proliferation, cell cycle, apoptosis, immune response and transcriptional regulation. JUNB was one of the genes up-regulated in PV and overexpression of JUNB was also detected by quantitative real time polymerase chain reaction (qRT-PCR) in hematopoietic cells of another two JAK2 V617F PV patients. Using Ba/F3-EPOR cell lines and primary human erythroblast cultures, JUNB was found to be expressed after Epo addition and JunB protein was shown to be constitutively induced by JAK2 V617F. In addition, JUNB knock down reduced the clonogenic and proliferative potential of human erythroid progenitors. Furthermore, in PV, the JAK2 V617F driven erythropoisis was more sensitive to JunB downregulation than normal erythropoiesis. Hence, these results demonstrate that JunB may play a major role in the development of JAK2 V617F myeloproliferative disorders

ASSUNTO(S)

hematopoese hematopoiesis fator de transcrição polycythemia policitemia transcription factor

Documentos Relacionados

• Expressão de microRNAs em leucócitos e células CD34+ em Policitemia Vera
• Pro- and anti-apoptotic genes and proteins expression in bone marrow precursors and peripheral blood leukocytes in polycythemia vera patients
• Estudo citogenético e pesquisa de mutações nos genes JAK2 e MPL em Policitemia vera, Mielofibrose primária e Trombocitemia essencial
• Gene expression study in citrus using linear models
• Perfis de ácido graxo e de expressão gênica global em ovinos deslanados